COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study.

Kasap Cuceoglu, Muserref; Batu, Ezgi Deniz; Bilginer, Yelda; Özen, Seza

Kasap Cuceoglu, Muserref; Batu, Ezgi Deniz; Bilginer, Yelda; Özen, Seza.

Kasap Cuceoglu M; Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Batu ED; Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Bilginer Y; Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Özen S; Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey sezaozen@hacettepe.edu.tr.

Ann Rheum Dis ; 80(6): e95, 2021 06.

Article in English | MEDLINE | ID: covidwho-1909672

Subject(s)

Antirheumatic Agents; COVID-19; Rheumatology; Antirheumatic Agents/therapeutic use; Child; Cross-Sectional Studies; Humans; SARS-CoV-2

Keywords

antirheumatic agents; systemic vasculitis; tumour necrosis factor inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatology / Antirheumatic Agents / COVID-19 Type of study: Observational study / Randomized controlled trials Limits: Child / Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2020-218341

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google